Title of cohort

    Study of the relations between global food behaviors and/or specific nutritional factors and ageing on a large population of mature adults

    Acronym for cohort

    SUVIMAX 2

    Name of Principal Investigator - Title

    Prof

    Name of Principal Investigator - First name

    Serge

    Name of Principal Investigator - Last name

    Hercberg

    Address of institution -Institution

    INSERM

    Address of institution - Street address

    EREN, SMBH, 74 rue Marcel Cachin

    Address of institution - City

    Bobigny

    Address of institution - Postcode

    93017

    Country

    France

    Website

    Funding source

    NR, Inserm, MGEN, Mederic, IPSEN, Pierre Fabre

    Q1a. Please indicate below if your cohort includes or expects to include, incidence of the following conditions?

    Neurodegenerative disease in general

    Q1b. When are studies on the above condition(s) expected to become possible?

    Already possible

    Q2a. In a single sentence what is the stated aim of the cohort?

    Study the relations between global eating behaviors and/or some specific nutritional factors an the global quality of ageing among this population

    Q2b. What distinguishes this cohort from other population cohorts?

    Clinical, biological and neuropsychological data as well as nutritional exposure

    Q3a. i) Number of publications that involve use of your cohort to date

    220

    Q3a.ii) Please give up to three examples of studies to date (Principal Investigator, Institution, Title of Study)

    Emmanuelle Kesse-Guyot, INRA, Healthy aging and Nutrition| Emmanuelle Kesse-Guyot, INRA, Cognitive performances and Nutrition

    Q3b. If data on research outputs are already available please paste the publication list/other data or provide a link to where these data are publicly available

    https://www.dropbox.com/s/yjgydbdzy4zng1x/Biblio%20SUVIMAX2.rtf?dl=0

    Q3c. If no research has been done as yet, please explain in a few sentences what information (i.e. research findings) you expect will be gained from the population

    Q4a. Study criteria: what is the age range of participants at recruitment? Age in years From:

    55

    Q4a. Study criteria: what is the age range of participants at recruitment? To:

    70

    Q4b. Study criteria: what are the inclusion criteria?

    Voluntary subjects, having participated to the SUI.VI.MAX cohort, and aged between 55 and 70.

    Q4c. Study criteria: what are the exclusion criteria?

    Q5. What is the size of the cohort (i.e. how many participants have enrolled)?

    5,001-10,000 participants

    Q6a. Please describe what measures are used to characterise participants

    We are working on health during aging overall. Clinical, biological and neuropsychological data have benne collected.

    Q6b. Are there additional measures for participants with a clinical disorder?

    Q6c. Are there defined primary and secondary endpoints (e.g. defined health parameters)?

    If yes please specify

    Q7. What is the study design (select all that apply)?

    Prospective cohort|Longitudinal

    Q8. Are your cases matched by

    Q9a. Does your study include a specialised subset of control participants?

    No

    Q9b. If your study includes a specialised subset of control participants please describe

    Q10a. i) Please enter the data collection start date

    01/01/2007

    Q10a. ii) Please enter the data collection end date

    01/01/2009

    Q10a. iii) Is data collection for this study

    Data analysis ongoing| Closed to new patients

    Q10b. If data collection is ongoing, are there plans to continue the cohort study beyond the current projected end date?

    Q11. Is data collected

    Only through the study

    Other please specify here

    Q12. Is there a system in place to enable re-contact with patients to ask about participation in future studies?

    Yes (participants given permission to be re-contacted via PIs)

    Q13a. Please give information on the format and availability of data stored in a database (1)

    Data summarised in database

    % available

    Q13a. Please give information on the format and availability of data stored in a database (2)

    No

    % available

    Q13a. Please give information on the format and availability of data stored in a database (3)

    No

    % available

    Q13a. Please give information on the format and availability of data stored in a database (4)

    No

    % available

    Other (please specify)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (1)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (2)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (3)

    % available

    Q13b. Please give information on the format and availability of data held as individual records (4)

    % available

    Please specify language used

    Q14a. Is data available to other groups?

    Yes

    Q14b. If data is available to other groups what is the access policy/mechanisms for access?

    Apply to PI or co-ordinator at resource| Access to industry

    Q15. What data sharing policy is specified as a condition of use?

    No policy exists

    Q16a. Are tissues/samples/DNA available to other groups?

    Yes

    Q16b i) If yes, please describe below:

    Living donors blood| Living donors: blood derivatives| Living donors: DNA

    Q16b. ii) In what form are tissues/samples/DNA supplied?

    Secondary samples: plasma| Secondary samples: DNA| Secondary samples: other (Serum)

    Q16b. iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data (Q14 above)?

    Yes

    Q17. Is information on biological characteristics available to other groups?

    If available for a subset please specify number of patients and % of total cohort

    Number of Patients

    3500

    % of total cohort

    50

Types: Population Cohorts
Member States: France
Diseases: Neurodegenerative disease in general
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF